Trial Profile
A Phase 2b study of M512101 in acne vulgaris for 12 weeks
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Ozenoxacin (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Maruho
- 03 Dec 2015 New trial record